However, elevated input costs and ambiguity around tariffs are concerning.Rezdiffra Sales Boost Madrigal (MDGL), Competition a WoeRezdiffra, approved for MASH, has given MDGL a regular source of income. However, competition in the target market is a matter for concern.QuidelOrtho (QDEL) Gains on Sales Amid Ongoing Solvency WoesPer the Zacks Analyst, strong product sales and promising lab potential support QuidelOrtho's growth, though competition, solvency concerns, and policy uncertainty pose risks.New UpgradesQualys (QLYS) Rides on Product Strength, Marketing EffortsPer the Zacks analyst, Qualys benefits from expanding product capabilities, which helps it gain customers. Increasing marketing efforts are also an upside.Growing Air Travel Aids Spirit (SPR), Poor Financials WoePer the Zacks analyst, growing air travel is boosting the shipset delivery of Spirit AeroSystems' commercial products.